The Radoff-JEC Group Issues Letter to Fellow Seer, Inc. Stockholders Correcting the Company’s Blatant Rewriting of History
The Radoff-JEC Group, which holds about 7.7% of Seer, Inc. (NASDAQ: SEER), issued a letter to stockholders ahead of Seer’s July 28, 2026 annual meeting. It urges votes “FOR” director nominees Howard H. Berman, Joshua S. Horowitz, and Luis E. Rinaldini, citing Seer’s stock decline since its 2020 IPO and alleged governance and performance concerns.
How this was made

The 30-second read
Why it matters
The key market-relevant element is the proxy contest framing: alleged board non-independence, criticism of management performance, and a push for an objective strategic review process.
Market read
A contested director election and strategic-review push can drive short-term sentiment and positioning around SEER into the annual meeting.
What to watch
The article provides allegations and voting recommendations but no new, verifiable filings or outcomes; traders should watch for Seer’s formal proxy materials, board rebuttal, and any disclosed acquisition/strategic-review process details.
Background
The Radoff-JEC Group issued a shareholder letter to Seer stockholders recommending votes for three director nominees ahead of the July 28, 2026 annual meeting.
Ticker impact
Radoff-JEC, holding about 7.7% of Seer, urges votes for director nominees ahead of the July 28, 2026 annual meeting.
Moderate volatility risk into the July 28 annual meeting, with sentiment skewing negative if investors view the claims as credible.
The article is a shareholder letter contesting board independence and alleging poor performance, which can influence proxy voting and perceived strategic direction, but it does not disclose new financial results or a definitive transaction.
Market effects
Limited direct sector read-across; primarily a governance and strategic-review signal for a single public biotech/health-tech name.
None material beyond US small/mid-cap sentiment around contested proxy fights.
Low; no cross-border deal, regulation, or macro catalyst described.
Counterpoint
Seer’s board may argue the letter is partisan and that the company’s strategic plan and independence structure are being mischaracterized.
Key entities
- public_companySeer, Inc.
NASDAQ-listed company subject of the shareholder letter and upcoming annual meeting vote.
- shareholder_groupRadoff-JEC Group
Holds about 7.7% of Seer’s outstanding common stock and recommends voting for specific director nominees.
- executiveOmid Farokhzad, M.D.
CEO and Chairman whose compensation, share sales, and strategic plan are criticized in the letter.
- director_nomineesHoward H. Berman, Ph.D.; Joshua S. Horowitz; Luis E. Rinaldini
Named as director election candidates the group recommends stockholders support.

